PN
Pinki Nirmal Sagar
About Pinki Nirmal Sagar
Data last updated:
Pinki Nirmal Sagar is a Director at Shukra Pharmaceuticals Limited (since 2023), Director at Navkar Urbanstructure Limited (since 2018) and Director at Achint Health Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma, Manufacturing and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹49.59 Cr; the largest is Shukra Pharmaceuticals Limited at ₹36.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Nov 2023 | 1993 | ₹36.79 Cr (FY 2025) | Active | |
| Director | 18 Apr 2018 | 1992 | ₹12.80 Cr (FY 2023) | Active | |
| Director | 01 Oct 2020 | 2020 | Active | ||
| Director | 02 May 2024 | 2024 | Active | ||
| Director | 10 Oct 2020 | 2020 | Active |
Board colleagues of Pinki Nirmal Sagar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pinki Nirmal Sagar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pinki Nirmal Sagar
Pinki Nirmal Sagar currently holds 5 directorships: Shukra Pharmaceuticals Limited (Director, since 25 Nov 2023, revenue ₹36.79 Cr (FY 2025)); Navkar Urbanstructure Limited (Director, since 18 Apr 2018, revenue ₹12.80 Cr (FY 2023)); Achint Health Private Limited (Director, since 01 Oct 2020); Shree Nemi Power Projects Private Limited (Director, since 02 May 2024); Achint Ancient Nutrition Private Limited (Director, since 10 Oct 2020).
Pinki Nirmal Sagar was first appointed on 18 Apr 2018 as Director at Navkar Urbanstructure Limited. The most recent appointment on record is 02 May 2024 at Shree Nemi Power Projects Private Limited.
The 2 current companies of Pinki Nirmal Sagar that report revenue have a combined latest revenue of ₹49.59 Cr: Shukra Pharmaceuticals Limited ₹36.79 Cr (FY 2025); Navkar Urbanstructure Limited ₹12.80 Cr (FY 2023).
The current boards of Pinki Nirmal Sagar's companies include Anar Jayeshbhai Patel (Shukra Pharmaceuticals Limited), Anar Jayeshbhai Patel (Shukra Pharmaceuticals Limited), Dakshesh Rameshchandra Shah (Shukra Pharmaceuticals Limited), Dhruvin Shah (Shukra Pharmaceuticals Limited), Dinesh Chauhan (Shukra Pharmaceuticals Limited), Jitendra Somchand Shah (Shukra Pharmaceuticals Limited), among others.